Key result
High-intensity rosuvastatin increases minimum fibrous-cap thickness by ~23 μm on AI-assisted OCT.
Why the study?
Does AI-assisted optical coherence tomography detect longitudinal coronary plaque stabilization changes in nonculprit vessels of STEMI patients treated with high-intensity rosuvastatin?
Cohort (n=33)
Does AI-assisted optical coherence tomography detect longitudinal coronary plaque stabilization changes in nonculprit vessels of STEMI patients treated with high-intensity rosuvastatin?
AI-assisted OCT analysis effectively detects a coronary plaque-stabilization signature (fibrous-cap thickening, decreased lipid burden, increased relative calcific burden) following high-intensity rosuvastatin therapy in STEMI patients.
Answers are grounded in this paper and cite their sources.
AI-assisted OCT plaque tracking on high-intensity statins needs prospective validation; leaves open its role in monitoring atherosclerosis.
The value of artificial intelligence (AI)-assisted optical coherence tomography (OCT) for assessing longitudinal changes in coronary plaque composition remains uncertain. We performed a post hoc, vessel-level substudy of the Integrated Biomarkers and Imaging Study-4 (IBIS-4), using AI-assisted tissue characterization of serial OCT images from nonculprit coronary vessels in patients with ST-segment elevation myocardial infarction treated with high-intensity rosuvastatin. Baseline and follow-up measurements were compared using paired nonparametric analyses. Serial analyzable imaging was available in 45 vessels from 33 patients. Minimum fibrous-cap thickness increased from 93.98 to 117.26 μm (p = 0.027), and mean cap thickness increased from 309.20 to 353.12 μm (p < 0.001). Lipid volume decreased from 28.36 to 22.88 mm³ (p = 0.002), and the relative lipid component decreased from 18.34% to 17.06% (p = 0.044). Relative fibrous tissue percentage increased from 70.10% to 74.52% (p = 0.001), whereas absolute fibrous tissue volume did not significantly change. Calcification volume did not significantly change (p = 0.307), but relative calcific burden increased from 7.60% to 8.49% (p = 0.020). In conclusion, AI-assisted analysis of serial IBIS-4 OCT imaging reproduced a plaque-stabilization signature characterized by fibrous-cap thickening, lower lipid burden, and increased calcific signal after high-intensity statin therapy, supporting further study of AI-assisted plaque analysis in longitudinal coronary imaging investigations.
No takes yet. Share an insight, caveat, or question.
Saboe et al. (2026) conducted a cohort in ST-segment elevation myocardial infarction (n=33). High-intensity rosuvastatin assessed by AI-assisted optical coherence tomography vs. Baseline measurements (paired pre- vs post-treatment comparison) was evaluated on Longitudinal changes in coronary plaque composition (minimum fibrous-cap thickness) (p=0.027). High-intensity rosuvastatin increased minimum fibrous-cap thickness from 93.98 to 117.26 μm and reduced lipid volume from 28.36 to 22.88 mm³ on AI-assisted OCT.
Synapse has enriched 10 related papers. Consider them for comparative context: